Some patients are naturally more sensitive to GLP-1 receptor activation, while others require higher doses to achieve comparable effects
While the prescribing information for GLP-1 medications does not specifically list Crohn's disease as a contraindication, the Summary of Product Characteristics (SmPC) for these medicines does advise caution in patients with gastrointestinal disease and states they are not recommended in severe gastrointestinal disease
When you hear medications like Ozempic or Wegovy mentioned, youre definitely hearing about GLP-1 medications. Learn more and find a provider GLP-1 medications are revolutionizing the treatment of Type 2 diabetes and obesity
Source: Polaris Market Research Analysis Growth Drivers Increasing usage of L-carnitine by consumers drives market growth
They review your medical history, discuss your symptoms, and explain your lab results in detail
With injectable therapies, side effects often track closely with the dosing schedule, peaking a day or two after the weekly injection is administered before tapering off as the week progresses
